Clinical Trials in Salt Lake City

Showing 2681-2700 of 7,997 trials

Phase III Efficacy and Safety Study of Miconazole Oil for Otomycosis

NCT05660382

The goal of this clinical trial is to prove the that miconazole oil works well on fungal infections of the ears, by comparing the drug with a placebo. The researcher or the participants will not know if they are getting the drug or the placebo. The researcher will show the participants how to use the drug or placebo. After 14 days of using the drug or placebo, the participants will be examined by the researcher and graded on how well the drug worked on the ear(s) fungal infection. Participants will also be checked and asked for any bad side effects from the drug or the placebo.

Otomycosis

Hill Dermaceuticals, Inc.100 participantsStarted Mar 2023

Chula Vista, California, United States • Louisville, Kentucky, United States • North Charleston, South Carolina, United States +4 more locations

COMPLETEDPhase 1< 1 mile

Immunotherapy With IFx-Hu2.0 Vaccine for Advanced Non-melanoma Skin Cancers

NCT04160065

In this clinical phase I, non-randomized, open-label, uncontrolled, interventional, multi-center trial, 20 adult subjects (≥ 18 years of age) with advanced non-melanoma skin cancers will receive a fixed dose of 0.1 mg of IFx-Hu2.0 intralesionally as monotherapy in up to three lesions at up to three time points. Subjects will be observed for any acute adverse events (AEs) post injection and for any delayed AEs at Day 28, 35 and/or 42 ± 7 days, depending on the cohort (exposure escalation and expansion design).

Merkel Cell CarcinomaCutaneous Squamous Cell CarcinomaNon-Melanoma Skin Cancers

TuHURA Biosciences, Inc.23 participantsStarted Mar 2020

Los Angeles, California, United States • Tampa, Florida, United States • Boston, Massachusetts, United States +1 more locations

Phase III Efficacy and Safety Study of Miconazole Oil for Otomycosis

Immunotherapy With IFx-Hu2.0 Vaccine for Advanced Non-melanoma Skin Cancers

Find Trials by Condition in Salt Lake City

Air Optix® Night and Day® Aqua Continuous Wear

A Study to Evaluate the Efficacy, Safety, and Concentration of SNS812 in Mild to Moderate COVID-19 Patients

Extension Study of Patidegib Topical Gel, 2% in Subjects With Gorlin Syndrome (Basal Cell Nevus Syndrome)

A Phase 2 Study to Evaluate the Efficacy and Safety of VIR-2482 for the Prevention of Illness Due to Influenza A

A Study to Evaluate Treatment Satisfaction With Erenumab in Participants With Migraine

A Study to Measure the Amount of Study Medicine in Blood in Adult Participants With COVID-19 and Severe Kidney Disease

Breast Cancer Index (BCI) Registry

A Study on the Immune Response and Safety Elicited by a Vaccine Against Respiratory Syncytial Virus (RSV) When Given Alone and Together With a Vaccine Against Influenza in Adults Aged 65 Years and Above

Study to Evaluate the Safety and Efficacy of CSB-001 Ophthalmic Solution 0.1% in Neurotrophic Keratitis Subjects

Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Children, Known or Suspected to be Caused by Susceptible Gram-positive Organisms, Including MRSA

Open-Label, Phase 1 Study to Evaluate Duration of Severe Neutropenia After Same-Day Dosing of Eflapegrastim in Patients With Breast-Cancer

Extension Study Evaluating NTX100 Neuromodulation System for Medication-Refractory Primary RLS

To Assess the Safety and Efficacy of SP-002 with Vismodegib for the Treatment of Locally Advanced Basal Cell Carcinoma

Luspatercept With or Without Hydroxyurea for the Treatment of Myelodysplastic/Myeloproliferative Neoplasms With Ring Sideroblasts and Thrombocytosis or Unclassifiable With Ring Sideroblasts

A Randomized Phase 2 Trial of TAS-114 in Combination With S-1 Versus S-1

A Study of Semorinemab in Patients With Moderate Alzheimer's Disease

Viz HCM (ECG Assist) Utilization Workflow Pilot

Engaging Staff to Improve COVID-19 Vaccination Response at Long-Term Care Facilities